Evidence map›Paper›PMID 39022389›Full record

ArticleOpen forum infectious diseases2024

Missed Opportunities for Preexposure Prophylaxis Initiation in Hospitalized Persons With Opioid Use Disorder and Infectious Diseases.

Kaley Parchinski, Victor Neirinckx, Cynthia Frank, Angela Di Paola, Adati Tarfa, Sheela Shenoi, Brent Vander Wyk, Prerana Roth, Tracy Ghantous, Mary Kay Wegman and 6 more

Abstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Open forum infectious diseases, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

16 authors.

Kaley ParchinskiSection of Infectious Diseases, Department of Internal Medicine, AIDS Program, Yale School of Medicine, New Haven, Connecticut, USA.ORCID https://orcid.org/0000-0001-5502-3056
Victor NeirinckxSection of Infectious Diseases, Department of Internal Medicine, AIDS Program, Yale School of Medicine, New Haven, Connecticut, USA.
Cynthia FrankSection of Infectious Diseases, Department of Internal Medicine, AIDS Program, Yale School of Medicine, New Haven, Connecticut, USA.
Angela Di PaolaSection of Infectious Diseases, Department of Internal Medicine, AIDS Program, Yale School of Medicine, New Haven, Connecticut, USA.
Adati TarfaSection of Infectious Diseases, Department of Internal Medicine, AIDS Program, Yale School of Medicine, New Haven, Connecticut, USA.
Sheela ShenoiSection of Infectious Diseases, Department of Internal Medicine, AIDS Program, Yale School of Medicine, New Haven, Connecticut, USA.
Brent Vander WykSection of Geriatrics, Department of Internal Medicine, Yale School of Medicine, New Haven, Connecticut, USA.
Prerana RothDepartment of Medicine, Prisma Health Addiction Medicine Center, Greenville, South Carolina, USA.
Tracy GhantousSection of Infectious Diseases, Department of Internal Medicine, AIDS Program, Yale School of Medicine, New Haven, Connecticut, USA.
Mary Kay WegmanSection of Infectious Diseases, Department of Internal Medicine, AIDS Program, Yale School of Medicine, New Haven, Connecticut, USA.
Michelle StrongDepartment of Medicine, Prisma Health Addiction Medicine Center, Greenville, South Carolina, USA.
Frances R LevinDepartment of Psychiatry, Columbia University Vagelos College of Physicians and Surgeons, New York City, New York, USA.
Kathleen BradyDepartment of Psychiatry, Medical University of South Carolina, Charleston, South Carolina, USA.
Edward NunesDepartment of Psychiatry, Columbia University Vagelos College of Physicians and Surgeons, New York City, New York, USA.
Alain H LitwinDepartment of Medicine, Prisma Health Addiction Medicine Center, Greenville, South Carolina, USA.ORCID https://orcid.org/0000-0002-6717-0288
Sandra A SpringerSection of Infectious Diseases, Department of Internal Medicine, AIDS Program, Yale School of Medicine, New Haven, Connecticut, USA.

Funding

Yale Clinical and Translational Science Award (U Component)UL1TR001863 · NCATS · YALE UNIVERSITY · PI John H. Krystal, LUCILA OHNO-MACHADO · 2016 to 2026
$102.9M
Yale Study Support Suite (YES3): Dashboard and Web Portal Software Supporting Research Workflow through integrated, customizable REDCap External ModulesP30AG021342 · NIA · YALE UNIVERSITY · PI Albert C Shaw · 2002 to 2026
$37.9M
Ending HIV: Bringing Integrated Prevention and Treatment Services to People Who Use Drugs Where They LiveDP1DA056106 · NIDA · YALE UNIVERSITY · PI SANDRA Ann SPRINGER · 2022 to 2026
$6.0M
Coordinated medical treatment of opioid use disorder and infectious diseaseU01TR002763 · NCATS · YALE UNIVERSITY · PI BRADY, KATHLEEN T., LEVIN, FRANCES RUDNICK · 2019 to 2022
$5.4M
NCATS NIH HHS U01 TR002763NCATS NIH HHS UL1 TR001863NIA NIH HHS P30 AG021342NIDA NIH HHS DP1 DA056106
6 · The paper itself

Abstract

Hospitalizations are increasing among persons who use opioids, secondary to overdose and infections. Our study identified acute hospitalization as a reachable moment for engaging people who use drugs in increased screening and education about human immunodeficiency virus risk and prevention (preexposure prophylaxis).

Indexed as

buprenorphineHIVhospitalizationinfectionopioid use disorderpreexposure prophylaxis

Identifiers

PMID39022389
PMCPMC11252843

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.